High-Concentration, Low-Volume Subcutaneous Formulation

Video Shorts

Why the Focus from Industry on Rare Diseases?
0:33
Why the Focus from Industry on Rare Diseases?
a year ago
by
Feliza Mirasol
John Hoekman, Junevity
0:34
Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity
a year ago
by
Christopher Cole
Daniel Fischer, Tevard
1:22
How tRNAs Could Revolutionize Treatment for Dravet & More
a year ago
by
Christopher Cole
Tore Bergsteiner
0:53
AI Boosts Early Disease Detection and Diagnostic Accuracy
a year ago
by
Christopher Cole
Dave Miller, PhD, Chief Scientific Officer, AustinPx
0:23
Why Onshoring Manufacturing Is a Smart Move Today
a year ago
by
Christopher Cole
Dave Miller, PhD, Chief Scientific Officer, AustinPx
0:29
From Nice to Have to Mandatory: Pharma’s Sustainability Makeover
a year ago
by
Christopher Cole
Dave Miller, PhD, Chief Scientific Officer, AustinPx
0:25
How Tailored Drug Formulations Create Patentable Innovations
a year ago
by
Christopher Cole
Simona Guidi, Associate Director, ProPharma
1:22
Operators Are the Main Source of Contamination in Pharmaceutical Manufacturing
a year ago
by
Christopher Cole